Archive for February, 2006



The House is expected to vote Thursday on a bill that would pre-empt all state food safety regulations that are more stringent than federal standards.

TAMPA - For the first time, the Food and Drug Administration has approved an antidepressant treatment that uses a skin patch.

Washington PostDrug Gets New-Use ApprovalWashington Post, United States - 1 hour ago… The action yesterday by the Food and Drug Administration, which came after the stock market closed, shows that at least some of these drugs are likely to …


FDA recently approved the use of Tamiflu for preventing influenza in children 1 to 12 years old. Tamiflu was already approved as a preventive agent in patients 13 and older, and it is approved for treating the flu in patients older than 1 year. …

FDA recently approved a new immune globulin product that is injected subcutaneously. The product, called Vivaglobin, is made by the German company ZLB Behring. Until now, immune globulin products have been administered either intravenously or intra…

New warnings have been added to the labeling for Paxil and generic paroxetine based on preliminary analyses of two recent unpublished epidemiologic studies. Both studies showed a relatively small increased risk for cardiac defects in infants born to…

Ortho Clinical Diagnostics has recalled certain lots of the company's Vitros HBsAg Confirmatory Kit. This kit is used to confirm the presence of the antigen after a positive test with the Vitros HBsAg Reagent pack. Because of a problem with a diluti…

Mallinckrodt and Palatin Technologies have withdrawn from the market the imaging agent NeutroSpec because of serious safety concerns. NeutroSpec is used in nuclear medicine to help diagnose patients with equivocal signs and symptoms of appendicitis….

Glaxo SmithKline has notified health professionals about reports of diabetic macular edema in patients receiving Avandia (rosiglitazone maleate) which is used to treat type 2 diabetes. These reports involved both new cases of macular edema and worsen…

Ligand Pharmaceuticals has notified healthcare professionals about revised labeling for Avinza morphine sulfate extended-release capsules. These changes highlight warnings that patients should not consume alcohol while taking the drug. These wa…

The Institute for Safe Medication Practices recently reported on mix-ups occuring between two drugs whose names sound and look alike: Amicar (aminocaproic acid) and Omacor. Amicar, an antifibrinolytic agent available for many years, is used to enhan…

Patients are now going to have more information about whether packaged foods contain ingredients to which they are allergic. Effective January 1, 2006, FDA is requiring food labels to state clearly whether the product includes ingredients that conta…

FDA recently approved the use of Tamiflu for preventing influenza in children 1 to 12 years old. Tamiflu was already approved as a preventive agent in patients 13 and older, and it is approved for treating the flu in patients older than 1 year.

FDA recently approved a new immune globulin product that is injected subcutaneously. The product, called Vivaglobin, is made by the German company ZLB Behring. Until now, immune globulin products have been administered either intravenously or intra…




About

You are currently browsing the Regulatory Affairs Syndicator weblog archives for February, 2006.

Longer entries are truncated. Click the headline of an entry to read it in its entirety.

Categories